← Eichor
Study identifier: NCT07151339 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia

Condition: Preeclampsia · HELLP Syndrome · Eclampsia  ·  Sponsor: University Hospital Schleswig-Holstein

PhaseN/A
Planned participants100
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)

This description comes directly from the study's public registry record.

Talk to the study team

Laura K Sievers, MD  ·  +49 431 500 23001  ·  Laura.Rakow@uksh.de

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital Schleswig- HolsteinKiel, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07151339